EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Syngene International's enterprise value is ₹262,141 Mil.
Syngene International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹10,939 Mil. Therefore, Syngene International's EV-to-EBITDA for today is 23.96.
The historical rank and industry rank for Syngene International's EV-to-EBITDA or its related term are showing as below:
BOM:539268'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.23 Med: 23.22 Max: 34.83
Current: 23.96
During the past 13 years, the highest EV-to-EBITDA of Syngene International was 34.83. The lowest was 12.23. And the median was 23.22.
BOM:539268's EV-to-EBITDA is ranked worse than 72.94% of 462
companies
in the Biotechnology industry
Industry Median: 9.49
vs BOM:539268: 23.96
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Syngene International EV-to-EBITDA Historical Data
The historical data trend for Syngene International's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Syngene International's EV-to-EBITDA
For the Biotechnology subindustry, Syngene International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syngene International's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Syngene International's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Syngene International's EV-to-EBITDA falls into.
Syngene International's current Enterprise Value is ₹262,141 Mil.
Syngene International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹10,939 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syngene International (BOM:539268) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Syngene International's PE Ratio for today is calculated as:
Syngene International's share price for today is ₹666.75.
Syngene International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹12.690.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Syngene International's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Syngene International (BOM:539268) Business Description
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:539268 has been successfully added to your 